2000
DOI: 10.1111/j.1532-5415.2000.tb04993.x
|View full text |Cite
|
Sign up to set email alerts
|

Improvement in Quality‐of‐Life Measures and Stimulation of Weight Gain After Treatment with Megestrol Acetate Oral Suspension in Geriatric Cachexia: Results of a Double‐Blind, Placebo‐Controlled Study

Abstract: In geriatric patients with weight loss or low body weight MA improves appetite and well-being after 12 weeks of treatment. During the 3 months of MA treatment, there was no statistically significant weight gain (> or =4 lbs). Three months after treatment, weight gain (> or =4 lbs) was significantly increased in MA-treated patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
115
0
1

Year Published

2002
2002
2011
2011

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 140 publications
(118 citation statements)
references
References 36 publications
(34 reference statements)
2
115
0
1
Order By: Relevance
“…[14][15][16][21][22][23][24][25][26][27] All four trials were small and only one was a blinded randomized control trial. [23][24][25][26][27] The most commonly studied medication was megestrol acetate. One study also looked at the use of dronabinol for unexplained weight loss.…”
Section: Pharmacologic Treatmentmentioning
confidence: 99%
See 1 more Smart Citation
“…[14][15][16][21][22][23][24][25][26][27] All four trials were small and only one was a blinded randomized control trial. [23][24][25][26][27] The most commonly studied medication was megestrol acetate. One study also looked at the use of dronabinol for unexplained weight loss.…”
Section: Pharmacologic Treatmentmentioning
confidence: 99%
“…[23][24][25][26][27] Sixtynine patients were randomly assigned to receive placebo or megestrol 800 mg/d for 12 weeks. At 12 weeks, there were no significant differences in weight gain between treatment groups, although patients treated with megestrol reported significantly greater improvements in appetite, enjoyment of life and well-being.…”
Section: Pharmacologic Treatmentmentioning
confidence: 99%
“…90,91 Evidence for its use with elderly people is limited. 89,[91][92][93] Ornithine oxoglutarate led to weight gain in one randomized trial but has not been studied in other trials. 86 There are no randomized trials of either cyproheptadine or dronabinol in elderly people with weight loss, although dronabinol has been studied in one trial involving patients with dementia who were refusing food.…”
Section: Pharmacologic Therapy To Reverse Weight Lossmentioning
confidence: 99%
“…However, in one study 50 depleted American nursing-home residents (mean age 76 years) were randomized to megestrol acetate treatment for 12 weeks. Together with improved appetite and small effects on weight, the patients reported a better sense of well-being (17).…”
Section: Macronutrient or Micronutrient Deficiency?mentioning
confidence: 95%